 "Wockhardt gains as German regulator clears Ankaleshwar plant")
Wockhardt was up 6% to Rs 713 on the BSE in early morning trade after the drug firm said German regulator has issued European Union Good Manufacturing Practice (EU GMP) certificate to the company's Ankaleshwar facility in Gujarat.
"The competent authority, Berlin, Germany has since issued Certificate confirming that company's manufacturing facility at 138, GIDC Estate, Ankaleshwar, Gujarat, complies with the principles and guidelines of Good Manufacturing Practices," Wockhardt said in a filing to BSE.
The certificate issued in this regard is valid for three years, it added.
The stock was under pressure hitting a 52-week low of Rs 627 on December 27, 2016 in intra-day trade. It fell 37% between August 5 and December 26 after the US Food and Drug Administration (USFDA) issued warning letter to the company for violating current good manufacturing practice norms at its Ankleshwar plant. The S&P BSE Sensex was down 8% during the same period.
"The competent authority, Berlin, Germany has since issued Certificate confirming that company's manufacturing facility at 138, GIDC Estate, Ankaleshwar, Gujarat, complies with the principles and guidelines of Good Manufacturing Practices," Wockhardt said in a filing to BSE.
The certificate issued in this regard is valid for three years, it added.
The stock was under pressure hitting a 52-week low of Rs 627 on December 27, 2016 in intra-day trade. It fell 37% between August 5 and December 26 after the US Food and Drug Administration (USFDA) issued warning letter to the company for violating current good manufacturing practice norms at its Ankleshwar plant. The S&P BSE Sensex was down 8% during the same period.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%